Immunosuppressant Therapy in Small Animal Medicine: What, When, and Why

Today's Vet Pract. Jul-Aug 2023;13(4):83-93. 49 Refs

Stuart A Walton¹, Alexis Hoelmer

¹ University of Florida College of Veterinary Medicine, Gainesville, Florida 32608, USA.

Author Abstract

Glucocorticoids are considered the mainstay of immunosuppressive therapy; however, clinicians should be aware of second-line or alternative agents.

Article Tools:

Email to me

Archives Highlights:

Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small-Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma.
The median time to distant progression for all dogs was 265 days, with no significant difference between treatment groups. The median overall survival for all dogs was 270 days, and it was significantly different between amputated dogs (150 days) and those also receiving adjuvant chemotherapy (353 days). In our cohort, osteosarcoma in small breeds behaved as aggressive as in large breeds.

Mass rabies exposure of veterinary health care workers in Germany: Management, immune response, and tolerability of post exposure-prophylaxis.
In 2008, Germany was declared free from terrestrial rabies by the WOAH. However, illegal pet imports can still lead to rabies exposure, as seen in the 2021 case of a rabid puppy illegally imported to Germany, resulting in a mass exposure (39 veterinary clinic staff) incident.

Resolution of egg binding is possible in most client-owned parrots when multiple treatment strategies are considered.
Of the 150 events that had complete follow-up, 109 (72.7%) resulted in a successful outcome. A successful outcome was observed in 44 of 133 events (33.1%) that were initially managed medically without resorting to additional treatment strategies, in 31 events (86.1%) managed with mechanical assistance, in 20 events (60.6%) managed surgically, and in 12 events (85.7%) managed with ovocentesis.

Effective treatment with afoxolaner (NexGard) of Trixacarus caviae in a pet guinea pig.
The animal was treated with a single oral dose of 2.50 mg/kg afoxolaner, and the lesions, presence/absence of mites, and intensity of pruritus were evaluated periodically until 2 months post-treatment. A week after the medication, the lesions were milder, but pruritus was still present and was attributed to the healing process. Further examinations showed significant improvement with the complete remission of clinical signs and no mites at the microscopic examination after 4 weeks.

Clinical characterization of a novel episodic ataxia in young working Cocker Spaniels.
The mean age at clinical onset was 4 months. Signs were acute and included episodic body swaying, titubation, cerebellar ataxia, wide-base stance, and hypermetria, all while mentation remained unaltered. Duration of episodes ranged from 30 minutes up to 24 hours, and their frequency varied from weekly to once every 5 months.